Orchid Pharma Ltd - 524372 - Shareholding for the Period Ended September 30, 2020
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here20-10-2020
20-10-2020
Orchid Pharma Ltd - 524372 - Shareholding for the Period Ended October 16, 2020
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended October 16, 2020. For more details, kindly Click here16-10-2020
Orchid Pharma Ltd - 524372 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30,202005-10-2020
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- Credit Rating05-10-2020
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of The SEBI (LODR )Regulations,2015
Disclosure under Regulation 30 of the SEBI (LODR )Regulations,201517-09-2020
Orchid Pharma Ltd - 524372 - Approval Of Unaudited Financial Results For The Quarter Ended June 30,2020
Approval of Unaudited financial results for the quarter ended June 30,202007-09-2020
Orchid Pharma Ltd - 524372 - Outcome Of Board Meeting- Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30,2020
Outcome of Board meeting- Approval of Unaudited financial results (Standalone and Consolidated) for the quarter ended June 30,202007-09-2020
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30 (LODR)- Withdrawal of Credit Rating01-09-2020
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30,2020
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/09/2020 ,inter alia, to consider and approve Unaudited Standalone and Consolidated financial results for the quarter ended June 30,202031-08-2020